Physician profile

David P Mason

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Dallas, TX

NPI 1083678155

$20,564.51

in general payments reported to CMS, 2019-2025

41 companies · $482 in 2025

The $482 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$5,370.00
Food and Beverage$1,213.53
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$930.00
Education$32.46

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $10,961.74 2019-2025 Tagrisso
Novocure INC. $4,863.80 2019-2021
Olympus Corporation of The Americas $1,104.92 2022
Medtronic, INC. $1,032.90 2023-2025 Signia, Aquamantys(Tm)
Intuitive Surgical, INC. $304.18 2019-2023
Ethicon US, LLC $244.92 2019-2025 Echelon; Endopath, Echelon Flex
Tela Bio, INC. $237.95 2022-2025 Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s
Olympus America INC. $204.44 2020-2025
Atricure, INC. $200.05 2019-2025 Atricure Cryoice Cryosphere Cryoablation System
Ambu INC. $182.32 2024
Davol INC. $87.98 2019-2023 Arista Ah Flexitip
Becton, Dickinson and Company $85.43 2019-2025 Progel Applicator Spray Tips
Kls-Martin L.P. $77.10 2020-2022
Potrero Medical, INC. $73.19 2021-2022
Baxter Healthcare $69.31 2022-2024 Perclot
Show all 41 companies
CompanyGeneral paymentsYearsTop products
La Jolla Pharmaceutical Company $66.25 2021
Avanos Medical $60.13 2019
Veran Medical Technologies, INC. $51.84 2019-2020
Bard Access Systems, INC. $46.99 2019
Merck Sharp & Dohme LLC $46.20 2024-2025 Keytruda
Novo Nordisk INC $45.89 2019
Stryker Corporation $45.42 2025 Na
Karl Storz Endoscopy-America $41.01 2023
Biom'Up France Sas $40.91 2020
Ethicon INC. $39.28 2021
Cook Medical LLC $37.55 2021
Abbott Laboratories $35.43 2022
Boston Scientific Corporation $28.31 2019
Edwards Lifesciences Corporation $26.76 2022
Octapharma USA, INC. $25.56 2025 Fibryga
Integra Lifesciences Corporation $24.30 2023 Biodrestore, Biodfactor, Medihoney
Mallinckrodt Hospital Products INC. $21.37 2020
Genentech USA, INC. $20.51 2019
Sanofi Pasteur INC. $18.33 2023
Smith+Nephew, INC. $17.28 2019
Janssen Pharmaceuticals, INC $16.94 2023 Xarelto
Lilly USA, LLC $16.86 2023 Emgality, Jardiance
Micro-Tech Endoscopy USA, INC. $16.24 2021
Mylan Specialty L.P. $15.48 2024 Yupelri
Vertex Pharmaceuticals Incorporated $14.78 2025
Nestle Healthcare Nutrition INC. $14.66 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David P Mason

$20,564.51

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $482 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).

https://glasscript.com/doctor/1105985/david-p-mason

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.